Individuals Stopping Weight-Loss Jabs Put On Weight Far More Rapidly Compared to Those on Conventional Diets

Fresh analysis indicates that individuals who stop using new slimming jabs like Wegovy and Mounjaro can put back on lost weight far faster than those who halt conventional diet and exercise regimens.

Research printed in a prominent health publication shows that while overweight individuals often shed a large proportion of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month upon discontinuation.

"People using these medications need to be aware of the potential of quick weight regain when the medication is stopped," warns expert Dr. Susan Jebb.

That rate of regain means a return to starting weight within about one and a half years.

Weighing Therapies

The research, which looked at 37 of studies involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with conventional dieting.

Researchers point out that people who shed pounds through dieting typically experience a more gradual creep back—approximately 0.1 kg a month—once they finish.

Understanding the Rapid Regain

Experts propose the mechanism of the injections explains the accelerated weight return.

The injections mimic a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Sustained high doses of the hormone concentrations far above than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication means hunger is unsuppressed, making overeating much more probable."

A Chronic Condition?

Health authorities recommend the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

Many experts contend that, due to the high risk of weight regain, the therapy might need to be life-long.

This view is reinforced by drug manufacturers, who state that the findings "emphasize the chronic character of excess weight," comparing it to managing conditions like diabetes.

Patient Accounts

Individuals who have discontinued the medication explain a intense return of cravings.

"I experienced something that goes on and I was suddenly starving," said a patient.

The struggle is worsened if patients have not developed sustainable lifestyle or habit modifications during treatment.

Widespread Adoption

Survey data show that millions of people in the UK have used weight-loss jabs in the past year, with demand remaining high.

• Adoption is more common among women than men.
• The middle-aged demographic shows the highest level of interest.
• A large proportion obtain the drugs through private healthcare rather than public health services.

In conclusion, researchers caution that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and long-term success relies on combined behavioural support.